TRAVERE THERAPEUTICS TVTX 深 沪
已收盘 07-26 16:00:00 美东时间
9.89
+0.120
+1.23%
华盛通- 最 高10.12
- 今 开9.93
- 成交量 67.26万股
- 最 低 9.69
- 昨 收 9.77
- 总市值 7.42亿
- 52周最高 17.5699
- 市盈率 静 --
- 换手率 0.90%
- 52周最低 5.12
- 委 比 68.43%
- 总股本 7501.09万
- 历史最高 37.04
- 量 比 0.91
- 振 幅 4.40%
- 历史最低 0.90
- 每 手 1
- 风险率 2.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on T...
07-09 22:05
Travere Therapeutics Shareholders Back Management and Growth Plan
Travere Therapeutics (TVTX) has provided an announcement. During the Annual Mee...
05-14 04:25
Travere Therapeutics shares are trading higher following Q1 earnings.
Travere Therapeutics shares are trading higher following Q1 earnings.
05-07 23:20
Notable earnings after Monday's close
Major earnings expected after the bell on Monday include: Palantir Technologies (PLTR) Realty Income Corporation (O) Lucid Group (LCID) Simon Property Group (SPG) Vertex Pharmaceuticals Incorporated (...
05-06 05:35
Travere, CSL win conditional nod for kidney disease therapy in EU
Travere Therapeutics (NASDAQ:TVTX) and CSL Vifor, the U.S. biotech's partner for its kidney disease drug Filspari, announced Wednesday that the European Commission granted conditional marketing author...
04-24 20:31
FYBR, BCRX and SABR are among after hour movers
Gainers: Travere Therapeutics (TVTX) +6%. Sabre Corporation (SABR) +5%. Nextracker (NXT) +3%. Cipher Mining (CIFR) +3%. BioCryst Pharmaceuticals (BCRX) +3%. Losers: Avidity Biosciences (RNA) -6%. Sa...
04-19 04:56
As more rare disease therapies launch, their prices are rising
Therapies that treat rare diseases are among the most expensive treatments for patients, with price tags often reaching seven figures. Despite their high price, the treatments are usually lucrative fo...
04-17 00:22
Guggenheim Downgrades Travere Therapeutics to Neutral
Guggenheim analyst Vamil Divan downgrades Travere Therapeutics (NASDAQ:TVTX) fr...
03-27 18:49
Further Weakness as Travere Therapeutics (NASDAQ:TVTX) Drops 14% This Week, Taking Three-year Losses to 72%
Every investor on earth makes bad calls sometimes. But you have a problem if yo...
03-15 21:42
盘前涨超7% Travere(TVTX.US)罕见肾病药FILSPARI获欧盟批准
Vifor Pharma及其合作伙伴Travere Therapeutics研发的FILSPARI(sparsentan)获得了欧洲药品监管机构的批准，该药物用于治疗罕见严重IgA肾病(IgAN)。
02-23 20:19
